ACAD

$0.00

(

0.00%

)
Quote details

stock

ACADIA Pharmaceuticals Inc

NASDAQ | ACAD

25.99

USD

$0.00

(

0.00%

)

At Close (As of Aug 29, 2025)

$4.38B

Market Cap

19.54

P/E Ratio

1.33

EPS

$26.65

52 Week High

$13.40

52 Week Low

LIFE SCIENCES

Sector

ACAD Chart

Recent Chart
Price Action

ACAD Technicals

Tags:

ACAD Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $876M
Total Revenue $958M
Cost Of Revenue $82M
Costof Goods And Services Sold $82M
Operating Income $231M
Selling General And Administrative $488M
Research And Development $303M
Operating Expenses $645M
Investment Income Net -
Net Interest Income $25M
Interest Income $25M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $16M
Income Before Tax $258M
Income Tax Expense $32M
Interest And Debt Expense -
Net Income From Continuing Operations $226M
Comprehensive Income Net Of Tax -
Ebit $84M
Ebitda $100M
Net Income $226M

Revenue & Profitability

Earnings Performance

ACAD Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.2B
Total Current Assets $938M
Cash And Cash Equivalents At Carrying Value $320M
Cash And Short Term Investments $320M
Inventory $22M
Current Net Receivables $105M
Total Non Current Assets $249M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $120M
Intangible Assets Excluding Goodwill $120M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $436M
Other Current Assets $56M
Other Non Current Assets -
Total Liabilities $455M
Total Current Liabilities $395M
Current Accounts Payable $16M
Deferred Revenue -
Current Debt -
Short Term Debt $10M
Total Non Current Liabilities $60M
Capital Lease Obligations $52M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $52M
Other Current Liabilities $299M
Other Non Current Liabilities $18M
Total Shareholder Equity $733M
Treasury Stock -
Retained Earnings -$2.2B
Common Stock $16K
Common Stock Shares Outstanding $166M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $158M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $16M
Capital Expenditures $523K
Change In Receivables -
Change In Inventory -$50M
Profit Loss -
Cashflow From Investment -$31M
Cashflow From Financing $6.8M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $226M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $876M
Total Revenue $958M
Cost Of Revenue $82M
Costof Goods And Services Sold $82M
Operating Income $231M
Selling General And Administrative $488M
Research And Development $303M
Operating Expenses $645M
Investment Income Net -
Net Interest Income $25M
Interest Income $25M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $16M
Income Before Tax $258M
Income Tax Expense $32M
Interest And Debt Expense -
Net Income From Continuing Operations $226M
Comprehensive Income Net Of Tax -
Ebit $84M
Ebitda $100M
Net Income $226M

ACAD News

ACAD Profile

ACADIA Pharmaceuticals Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company is headquartered in San Diego, California.

NXTT
+52.17%
$0.44
IPDN
+246.63%
$6.69
NVDA
-3.32%
$174.18
CGBS
-39.47%
$0.03
GMHS
+68.14%
$1.90
LCID
-4.34%
$1.98
MRVL
-18.60%
$62.86
CARM
-5.70%
$0.21
NUKK
+31.97%
$4.87
IXHL
+6.63%
$0.65
BABA
+12.90%
$135.00
SOUN
+3.91%
$13.02
TSLA
-3.50%
$333.87
SRXH
+14.49%
$0.41
SNAP
+0.56%
$7.14
IREN
+14.93%
$26.48
DNN
+5.45%
$2.31
TNFA
-21.59%
$0.04
ELAN
-0.54%
$18.35
TPIC
-45.91%
$0.12
CIFR
+8.83%
$7.64
AAL
+0.90%
$13.37
AXDX
-61.36%
$0.03
MARA
+0.12%
$15.98
INTC
-2.32%
$24.35
WBD
-3.44%
$11.64
NIO
-1.99%
$6.38
SMX
+14.94%
$2.00
ONDS
+2.80%
$5.86
LYT
-16.77%
$0.09
SOFI
-1.92%
$25.54
TLRY
-6.12%
$1.38
RR
-1.61%
$3.04
RAYA
-12.59%
$0.04
PLTR
-0.89%
$156.71
F
+0.51%
$11.77
AFRM
+10.58%
$88.46
RGTI
-2.11%
$16.23
ADAP
-14.51%
$0.05
CGC
-4.25%
$1.80
RMBL
+60.50%
$3.21
IQ
+5.57%
$2.65
GOOGL
+0.60%
$212.91
RIVN
-0.51%
$13.57
DUO
+53.20%
$2.39
AAPL
-0.18%
$232.14
ETHD
+4.66%
$3.59
ADD
-25.47%
$0.05
AMD
-3.52%
$162.63
PFE
+0.65%
$24.76
SMCI
-5.52%
$41.54
YYAI
-15.96%
$3.21
GRAB
+0.40%
$4.99
RIOT
-0.28%
$13.76
WULF
+0.10%
$9.44
SRM
+53.27%
$10.30
BMNR
-4.27%
$43.62
BAC
+0.49%
$50.74
PLUG
-3.68%
$1.57
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BBD
0.00%
$3.11
WLGS
-5.57%
$0.04
APLD
-3.73%
$15.98
BTG
+2.22%
$4.13
GAP
+1.52%
$22.01
ABEV
+0.44%
$2.24
ETWO
0.00%
$3.30
T
+1.20%
$29.29
GRYP
-10.46%
$1.54
AMZN
-1.12%
$229.00
JOBY
-0.84%
$14.15
AIRE
-0.38%
$0.38
GOOG
+0.54%
$213.53
RIG
-2.25%
$3.03
CRWV
+0.24%
$103.04
STFS
+9.20%
$0.14
KHC
+2.64%
$27.97
AFMD
-34.94%
$0.18
BITF
+1.51%
$1.34
BINI
-18.25%
$0.26
MULN
-18.25%
$0.26
HBAN
+0.05%
$17.80
OPAD
-17.33%
$5.15
AG
+2.06%
$9.14
SRPT
-0.76%
$18.20
HOOD
+0.32%
$104.03
KDP
-0.68%
$29.09
AVGO
-3.64%
$297.39
ACHR
-2.71%
$8.94
KEY
+0.05%
$19.36
SBET
-3.46%
$17.82
BTBT
-1.53%
$2.57
MSFT
-0.57%
$506.69
BULL
-7.36%
$13.59
UP
-11.21%
$2.93
HL
+5.45%
$8.51
FSM
+3.35%
$7.70
QBTS
-1.88%
$15.62
HPE
-2.54%
$22.57
NXTT
+52.17%
$0.44
IPDN
+246.63%
$6.69
NVDA
-3.32%
$174.18
CGBS
-39.47%
$0.03
GMHS
+68.14%
$1.90
LCID
-4.34%
$1.98
MRVL
-18.60%
$62.86
CARM
-5.70%
$0.21
NUKK
+31.97%
$4.87
IXHL
+6.63%
$0.65
BABA
+12.90%
$135.00
SOUN
+3.91%
$13.02
TSLA
-3.50%
$333.87
SRXH
+14.49%
$0.41
SNAP
+0.56%
$7.14
IREN
+14.93%
$26.48
DNN
+5.45%
$2.31
TNFA
-21.59%
$0.04
ELAN
-0.54%
$18.35
TPIC
-45.91%
$0.12
CIFR
+8.83%
$7.64
AAL
+0.90%
$13.37
AXDX
-61.36%
$0.03
MARA
+0.12%
$15.98
INTC
-2.32%
$24.35
WBD
-3.44%
$11.64
NIO
-1.99%
$6.38
SMX
+14.94%
$2.00
ONDS
+2.80%
$5.86
LYT
-16.77%
$0.09
SOFI
-1.92%
$25.54
TLRY
-6.12%
$1.38
RR
-1.61%
$3.04
RAYA
-12.59%
$0.04
PLTR
-0.89%
$156.71
F
+0.51%
$11.77
AFRM
+10.58%
$88.46
RGTI
-2.11%
$16.23
ADAP
-14.51%
$0.05
CGC
-4.25%
$1.80
RMBL
+60.50%
$3.21
IQ
+5.57%
$2.65
GOOGL
+0.60%
$212.91
RIVN
-0.51%
$13.57
DUO
+53.20%
$2.39
AAPL
-0.18%
$232.14
ETHD
+4.66%
$3.59
ADD
-25.47%
$0.05
AMD
-3.52%
$162.63
PFE
+0.65%
$24.76
SMCI
-5.52%
$41.54
YYAI
-15.96%
$3.21
GRAB
+0.40%
$4.99
RIOT
-0.28%
$13.76
WULF
+0.10%
$9.44
SRM
+53.27%
$10.30
BMNR
-4.27%
$43.62
BAC
+0.49%
$50.74
PLUG
-3.68%
$1.57
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BBD
0.00%
$3.11
WLGS
-5.57%
$0.04
APLD
-3.73%
$15.98
BTG
+2.22%
$4.13
GAP
+1.52%
$22.01
ABEV
+0.44%
$2.24
ETWO
0.00%
$3.30
T
+1.20%
$29.29
GRYP
-10.46%
$1.54
AMZN
-1.12%
$229.00
JOBY
-0.84%
$14.15
AIRE
-0.38%
$0.38
GOOG
+0.54%
$213.53
RIG
-2.25%
$3.03
CRWV
+0.24%
$103.04
STFS
+9.20%
$0.14
KHC
+2.64%
$27.97
AFMD
-34.94%
$0.18
BITF
+1.51%
$1.34
BINI
-18.25%
$0.26
MULN
-18.25%
$0.26
HBAN
+0.05%
$17.80
OPAD
-17.33%
$5.15
AG
+2.06%
$9.14
SRPT
-0.76%
$18.20
HOOD
+0.32%
$104.03
KDP
-0.68%
$29.09
AVGO
-3.64%
$297.39
ACHR
-2.71%
$8.94
KEY
+0.05%
$19.36
SBET
-3.46%
$17.82
BTBT
-1.53%
$2.57
MSFT
-0.57%
$506.69
BULL
-7.36%
$13.59
UP
-11.21%
$2.93
HL
+5.45%
$8.51
FSM
+3.35%
$7.70
QBTS
-1.88%
$15.62
HPE
-2.54%
$22.57

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.